Helena Hachul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helena Hachul has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
Sergio Tufik
Universidade Federal de São Paulo (UNIFESP)
83 shared publications- Lia Rita Azeredo Bittencourt
Universidade Federal de São Paulo, Brazil
26 shared publications Monica L. Andersen
Departamento de Psicobiologia, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
20 shared publicationsMonica Levy Andersen
Departamento de Psicobiologia, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
18 shared publications- Monica Levy Andersen
Instituto do Sono, Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, Brazil
18 shared publications S. Tufik
Sleep Institute, AFIP, São Paulo, Brazil
16 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by World Public Health Nutrition Association in World Nutrition
- Vol. 17 (3) , 155-158
Sleep, Tryptophan Metabolism, and Breast Cancer: Implications for Public Health Nutrition
Breast cancer remains the most frequently diagnosed cancer among women worldwide and represents a major public health challenge. Sleep disturbances are highly prevalent in women with breast cancer and have been associated with impaired quality of life, circadian disruption, immune dysregulation, and adverse clinical outcomes. Tryptophan metabolism has emerged as a potential biological link between sleep regulation and breast cancer through its roles in serotonin and melatonin synthesis and the kynurenine pathway, which is implicated in tumor progression and immune modulation. This commentary discusses current evidence on the complex and context-dependent role of tryptophan metabolism, highlighting its relevance to sleep health, cancer biology, and discusses nutritional strategies from a public health perspective. While adequate dietary tryptophan may contribute to sleep regulation and well-being, excessive activation of tryptophan catabolism through the kynurenine pathway may promote an immunosuppressive tumor microenvironment. Therefore, current evidence does not support tryptophan supplementation in women with active breast cancer. Further clinical and translational studies are needed to clarify the therapeutic potential and safety of targeting tryptophan metabolism in breast cancer care.
- 30 September 2026
- Published by World Public Health Nutrition Association in World Nutrition
- Vol. 17 (3) , 155-158
Open AccessSleep, Tryptophan Metabolism, and Breast Cancer: Implications for Public Health Nutrition
Breast cancer remains the most frequently diagnosed cancer among women worldwide and represents a major public health challenge. Sleep disturbances are highly prevalent in women with breast cancer and have been associated with impaired quality of life, circadian disruption, immune dysregulation, and adverse clinical outcomes. Tryptophan metabolism has emerged as a potential biological link between sleep regulation and breast cancer through its roles in serotonin and melatonin synthesis and the kynurenine pathway, which is implicated in tumor progression and immune modulation. This commentary discusses current evidence on the complex and context-dependent role of tryptophan metabolism, highlighting its relevance to sleep health, cancer biology, and discusses nutritional strategies from a public health perspective. While adequate dietary tryptophan may contribute to sleep regulation and well-being, excessive activation of tryptophan catabolism through the kynurenine pathway may promote an immunosuppressive tumor microenvironment. Therefore, current evidence does not support tryptophan supplementation in women with active breast cancer. Further clinical and translational studies are needed to clarify the therapeutic potential and safety of targeting tryptophan metabolism in breast cancer care.
- Open Access
- 30 September 2026
- Published by Chronobiology in Medicine in Chronobiology in Medicine
- Vol. 8 (3) , 182-183
The Circadian Gap in Type 2 Diabetes Care
- 30 September 2026
- Published by Chronobiology in Medicine in Chronobiology in Medicine
- Vol. 8 (3) , 182-183
Open AccessThe Circadian Gap in Type 2 Diabetes Care
- 27 September 2026
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 170
Dietary intake, sleep assessment, and chronotype in time-restricted eating feasibility protocols
- 27 September 2026
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 170
Dietary intake, sleep assessment, and chronotype in time-restricted eating feasibility protocols
- 6 April 2026
- Published by SAGE Publications in Obstetric Medicine
- Vol. 19 (3) , 223-224
Circadian misalignment, dietary timing, and maternal morbidity
- 6 April 2026
- Published by SAGE Publications in Obstetric Medicine
- Vol. 19 (3) , 223-224
Circadian misalignment, dietary timing, and maternal morbidity
- 3 March 2026
- Published by Wolters Kluwer Health in Menopause
- Vol. 33 (7) , 820-826
Climacteric and sleep in women with prior COVID-19: pilot study
Objectives: To evaluate sleep quality, hot flashes, and climacteric symptoms in women with prior SARS-CoV-2 infection at the Women’s Sleep Clinic of Hospital São Paulo. To determine the prevalence of SARS-CoV-2 infection in this Clinic and to compare sleep quality, frequency of hot flashes, and climacteric symptoms between women with a previous SARS-CoV-2 infection and those without. Methods: This is an analytical, observational, cross-sectional study, using a convenience sample from a Women’s Sleep Clinic. The evaluation was conducted using the Menopause Rating Scale, the Pittsburgh Sleep Quality Index, the Kupperman Index, questions about previous SARS-CoV-2 infection, daily frequency of hot flashes, and sociodemographic data. Eighty-five women were included in the study, and the sample was distributed among women with prior SARS-CoV-2 infection (34) and women without (51). Group comparisons were performed using Generalized Linear Models (GzLM) with appropriate distributions, and associations were analyzed with Spearman correlation, with P P =0.001) and sexual (3.42±0.33; Wald=6.38; P =0.012) domains of the Menopause Rating Scale, reflecting a worse overall quality of life score (4.35±0.23; Wald=8.71; P =0.003). Conclusion: In this pilot study, comparison between groups, women with previous SARS-CoV-2 infection had worse levels in the physical and sexual domains of the Menopause Rating Scale.
- 3 March 2026
- Published by Wolters Kluwer Health in Menopause
- Vol. 33 (7) , 820-826
Climacteric and sleep in women with prior COVID-19: pilot study
Objectives: To evaluate sleep quality, hot flashes, and climacteric symptoms in women with prior SARS-CoV-2 infection at the Women’s Sleep Clinic of Hospital São Paulo. To determine the prevalence of SARS-CoV-2 infection in this Clinic and to compare sleep quality, frequency of hot flashes, and climacteric symptoms between women with a previous SARS-CoV-2 infection and those without. Methods: This is an analytical, observational, cross-sectional study, using a convenience sample from a Women’s Sleep Clinic. The evaluation was conducted using the Menopause Rating Scale, the Pittsburgh Sleep Quality Index, the Kupperman Index, questions about previous SARS-CoV-2 infection, daily frequency of hot flashes, and sociodemographic data. Eighty-five women were included in the study, and the sample was distributed among women with prior SARS-CoV-2 infection (34) and women without (51). Group comparisons were performed using Generalized Linear Models (GzLM) with appropriate distributions, and associations were analyzed with Spearman correlation, with P P =0.001) and sexual (3.42±0.33; Wald=6.38; P =0.012) domains of the Menopause Rating Scale, reflecting a worse overall quality of life score (4.35±0.23; Wald=8.71; P =0.003). Conclusion: In this pilot study, comparison between groups, women with previous SARS-CoV-2 infection had worse levels in the physical and sexual domains of the Menopause Rating Scale.
- Open Access
- 1 January 2026
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 40, 1-2
Evaluating sleep and dietary assessment within composite lifestyle scores: Implications for mortality research in type 2 diabetes
- 1 January 2026
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 40, 1-2
Open AccessEvaluating sleep and dietary assessment within composite lifestyle scores: Implications for mortality research in type 2 diabetes
- Open Access
- 31 December 2025
- Published by Georg Thieme Verlag KG in Sleep Science
- Vol. 18 (04) , e410-e419
Is Anxiety Associated with Vasomotor Symptoms in Postmenopausal Women with Insomnia Complaints?
This study investigated the relationship between hot flashes, menopausal symptoms, anxiety, depression, and insomnia in postmenopausal women with insomnia complaints. A cross-sectional analysis was conducted with 71 postmenopausal women experiencing insomnia, divided into two groups based on the presence of vasomotor symptoms: 41 participants reported hot flashes in the past month, while 30 did not. All participants completed validated questionnaires, including the Blatt-Kupperman Menopausal Index, Menopause Rating Scale (MRS), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Insomnia Severity Index (ISI). Women experiencing hot flashes showed a significant association between elevated anxiety levels and menopausal symptoms. Across the entire sample, anxiety levels strongly correlated with the severity of menopausal symptoms. Participants with hot flashes were more likely to be classified as having severe anxiety based on BAI results compared with those without vasomotor symptoms. However, no significant differences were found in depression or insomnia severity between the groups. Vasomotor symptoms are associated with higher anxiety levels and more pronounced menopausal symptoms in postmenopausal women with insomnia complaints. These findings highlight the potential impact of hot flashes on emotional well-being and overall health during postmenopause.
- 31 December 2025
- Published by Georg Thieme Verlag KG in Sleep Science
- Vol. 18 (04) , e410-e419
Open AccessIs Anxiety Associated with Vasomotor Symptoms in Postmenopausal Women with Insomnia Complaints?
This study investigated the relationship between hot flashes, menopausal symptoms, anxiety, depression, and insomnia in postmenopausal women with insomnia complaints. A cross-sectional analysis was conducted with 71 postmenopausal women experiencing insomnia, divided into two groups based on the presence of vasomotor symptoms: 41 participants reported hot flashes in the past month, while 30 did not. All participants completed validated questionnaires, including the Blatt-Kupperman Menopausal Index, Menopause Rating Scale (MRS), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Insomnia Severity Index (ISI). Women experiencing hot flashes showed a significant association between elevated anxiety levels and menopausal symptoms. Across the entire sample, anxiety levels strongly correlated with the severity of menopausal symptoms. Participants with hot flashes were more likely to be classified as having severe anxiety based on BAI results compared with those without vasomotor symptoms. However, no significant differences were found in depression or insomnia severity between the groups. Vasomotor symptoms are associated with higher anxiety levels and more pronounced menopausal symptoms in postmenopausal women with insomnia complaints. These findings highlight the potential impact of hot flashes on emotional well-being and overall health during postmenopause.
- 9 June 2025
- Published by SAGE Publications in Journal of Health Psychology
- Vol. 31 (1) , 314-331
Effects of insomnia symptoms on quality of life and mood in women: EPISONO cohort study
This study used data from the Sao Paulo Epidemiologic Sleep Study (EPISONO) undertaken in 2007, with a follow-up study in 2015. Women who took part in both editions of the study were distributed in two groups: those with insomnia symptoms (GIS) and those without insomnia symptoms (GWIS). To evaluate groups over time, the Chalder Fatigue Questionnaire, the Beck Anxiety Inventory, the Beck Depression Index, and the World Health Organization Quality of Life assessment were used. Additionally, full-night polysomnography was used to assess the participants’ sleep pattern. The GWIS presented significantly less fatigue, anxiety, and depression, and better results in all domains of quality of life, in both EPISONO editions. Moreover, time had a significant impact on the levels of fatigue and depression, regardless of groups. Insomnia symptoms were associated with higher levels of fatigue, anxiety and depression and a lower perception of quality of life, regardless of time.
- 9 June 2025
- Published by SAGE Publications in Journal of Health Psychology
- Vol. 31 (1) , 314-331
Effects of insomnia symptoms on quality of life and mood in women: EPISONO cohort study
This study used data from the Sao Paulo Epidemiologic Sleep Study (EPISONO) undertaken in 2007, with a follow-up study in 2015. Women who took part in both editions of the study were distributed in two groups: those with insomnia symptoms (GIS) and those without insomnia symptoms (GWIS). To evaluate groups over time, the Chalder Fatigue Questionnaire, the Beck Anxiety Inventory, the Beck Depression Index, and the World Health Organization Quality of Life assessment were used. Additionally, full-night polysomnography was used to assess the participants’ sleep pattern. The GWIS presented significantly less fatigue, anxiety, and depression, and better results in all domains of quality of life, in both EPISONO editions. Moreover, time had a significant impact on the levels of fatigue and depression, regardless of groups. Insomnia symptoms were associated with higher levels of fatigue, anxiety and depression and a lower perception of quality of life, regardless of time.
- Open Access
- 24 January 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (3) , 368-369
Can Dietary Acid Load in Obese Adolescents Interfere with Cardiometabolic Risk, Psychological Resilience and Sleep Quality?
Can Dietary Acid Load in Obese Adolescents Interfere with Cardiometabolic Risk, Psychological Resilience and Sleep Quality? - Journal of Clinical Research in Pediatric Endocrinology
- 24 January 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (3) , 368-369
Open AccessCan Dietary Acid Load in Obese Adolescents Interfere with Cardiometabolic Risk, Psychological Resilience and Sleep Quality?
Can Dietary Acid Load in Obese Adolescents Interfere with Cardiometabolic Risk, Psychological Resilience and Sleep Quality? - Journal of Clinical Research in Pediatric Endocrinology